BI
IART icon

Binnacle Investments’s Integra LifeSciences IART Stock Holding History

Binnacle Investments’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$115 Buy
+8
New +$110 ﹤0.01% 924

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Binnacle Investments's IART Position: Q3 2025 in Review

Binnacle Investments opened a new position in Integra LifeSciences (IART) in Q3 2025: 8 shares worth $115. The stake represents ﹤0.01% of the portfolio and ranks #924 among its holdings.

207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

  • Binnacle Investments held 8 shares of Integra LifeSciences worth $115 as of Q3 2025.
  • Integra LifeSciences was a new Binnacle Investments position in Q3 2025.
  • Integra LifeSciences made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #924 holding.
  • 207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.